Victoria General Hospital is a hospital in Halifax, Nova Scotia, Canada, and part of the Queen Elizabeth II Health Sciences Centre, which began as the City Hospital in 1859.

There are 900 beds in Victoria General Hospital.

During the past decade, Victoria General Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Victoria General Hospital" #1 sponsor was "Nova Scotia Health Authority" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Brennan Eadie" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Atlantic Center for Oral and Maxillofacial Surgery" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Victoria General Hospital" #1 collaborator was "Canadian Frailty Network" with 1 trials as a collaborator, "Canadian Malnutrition Task Force" with 1 trials as a collaborator, "Chiron Corporation" with 1 trials as a collaborator and "Hamilton Health Sciences Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Victoria General Hospital" are "HIV Infections" (4 trials), "Glaucoma" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Victoria General Hospital" in a lesser frequency.

Most popular intervention types in "Victoria General Hospital" are "Drug" (12 trials), "Diagnostic Test" (3 trials), "Device" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Visual Field Testing" (2 trials), "Cefazolin, Cephalexin, Clindamycin" (1 trials), "Clay" (1 trials) and "Colchicine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Victoria General Hospital" are 18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Victoria General Hospital". 2 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Victoria General Hospital, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Victoria General Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".